Chris Kelly
See the following -
Trial Designed With Crowd Input Gets FDA Signoff
Marc Iskowitz | MM&M | December 28, 2012
What's been called the first clinical study protocol developed using crowdsourcing methods received the FDA's imprimatur earlier this month. The agency approved Transparency Life Sciences' IND for a clinical trial designed to test a generic blood-pressure medication, ACE inhibitor lisinopril, in patients with relapsing remitting multiple sclerosis. Read More »
- Login to post comments